Investors & Media

SEC Filings

Document Details

Form
Filing Date
May 13, 2022
Document Date
May 11, 2022
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
NGM Biopharmaceuticals, Inc.
Issuer
NGM BIOPHARMACEUTICALS INC
Filer
GOEDDEL DAVID V

Contact Information

investor relations

ir@ngmbio.com

media relations

media@ngmbio.com